Company profile: YPrime
1.1 - Company Overview
Company description
- Provider of eClinical solutions to expedite patient management, clinical supplies, and data in clinical trials, including IRT for patient randomization and drug supply management; eCOA for electronic collection of patient-, clinician-, and observer-reported outcomes; eConsent; patient engagement services and technologies; and clinical consulting to optimize processes, customize data collection, and integrate systems.
Products and services
- ECOA: Electronic system collecting patient-reported, clinician-reported, and observer-reported outcomes during clinical trials, supporting patient management and improving drug & clinical data quality
- EConsent: Digital process to obtain informed consent from clinical trial participants, supporting participant management and improving drug & clinical data handling quality across studies
- IRT: Trial-scale tool managing patient randomization and drug supply in clinical trials, expediting patient management and clinical supplies across studies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to YPrime
Medable
HQ: United States
Website
- Description: Provider of a global decentralized clinical trial platform powered by patient-generated data that streamlines design, recruitment, retention, and data quality, replaces siloed systems with integrated digital tools, data, and interfaces to accelerate trial execution, and connects patients, sites, and clinical trial teams to improve patient access, experience, and outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medable company profile →
Proxeon
HQ: Denmark
Website
- Description: Provider of solutions addressing scientific and technical challenges in proteomics, leveraging multidisciplinary expertise across biology, physics, engineering and informatics, developed by scientists actively involved in proteomics research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Proxeon company profile →
Genuity Science
HQ: United States
Website
- Description: Provider of clinco-omics data analysis solutions and genomic sequence data for researchers, with a platform for study design, sequencing, storage, interpretation, secondary analysis, and scalable analytics. Offers disease-specific clinical omics datasets (CNS, cardiometabolic, inflammatory), powered datasets, deeply phenotyped whole genomes, longitudinal data, and population-scale expertise applying deep learning to improve patient health using the human genome.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genuity Science company profile →
Republic M
HQ: Germany
Website
- Description: Provider of digital interactions and platforms to maximize behavioral change of healthcare professionals, including remote 1:1 selling engagements between key account managers and HCPs, peer-to-peer virtual and hybrid sessions with key opinion leaders, HCP profiling, custom portals and apps, and a SaaS platform integrating client-HCP interactions via a single interface.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Republic M company profile →
Emerald Cloud Lab
HQ: United States
Website
- Description: Provider of technology platforms for biotechnology innovation, including ECL Command Center for remote experiment design and execution; ECL Constellation for organizing data into a knowledge graph; access to 200+ automated lab instruments (HPLC, Mass Spectrometry, NMR); and 4,500+ data visualization, analysis, and simulation functions via point-and-click or direct command entry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emerald Cloud Lab company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for YPrime
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to YPrime
2.2 - Growth funds investing in similar companies to YPrime
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for YPrime
4.2 - Public trading comparable groups for YPrime
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →